ChartsView - Stock Trading Community

Microchip Technology (MCHP) — Company Research

Last Updated: 29 June 2026

Microchip Technology (NASDAQ: MCHP) is a Chandler, Arizona broadline supplier of microcontrollers, analog, FPGA and connectivity chips for the industrial, automotive, data-centre, aerospace & defence, communications and consumer markets. Fiscal 2026 (the year ended 31 March 2026) marked the turning point in one of the deepest downcycles in the company's history: after net sales collapsed from a record $8.44bn in FY2023 to $4.40bn in FY2025, revenue grew 7.1% to $4.713bn in FY2026, the March quarter rose 35.1% year over year, and management's nine-point recovery plan delivered sharply rising margins. This report walks through what Microchip does, how the numbers actually look against primary filings, the valuation it now carries after a strong run, and the risks that remain. For live pricing see our Live Charts, and track reporting dates on the Economic Calendar.

1. Company Snapshot

FieldValue
Ticker / ExchangeMCHP / NASDAQ
HeadquartersChandler, Arizona, USA
CEOSteve Sanghi (President, CEO & Chair)
CFOEric Bjornholt (SVP & CFO)
Employees~17,900 (FY2026 10-K)
Fiscal year end31 March
FY2026 revenue (net sales)$4,713.1m (+7.1% YoY)
FY2026 GAAP EPS (diluted)$0.22
FY2026 non-GAAP EPS (diluted)$1.64
Market cap~$51.0bn (late June 2026)
Dividend$0.455 per share quarterly (~$1.82 annualised)

2. Bull and Bear Case

Bull Case

  • Cyclical recovery underway: After bottoming in FY2025, net sales rose 35.1% year over year in the March 2026 quarter to $1.311bn and management guided the June 2026 quarter to ~$1.456bn at the midpoint (+35.3% YoY), with non-GAAP gross margin guided to 62.25%–63.25% as factory utilisation rebuilds.
  • Operating leverage returning: Non-GAAP operating margin recovered to 30.6% of sales in Q4 FY2026 from 14.0% a year earlier, and full-year non-GAAP EPS rose 25.2% to $1.64 even though revenue grew only 7.1% — evidence of the leverage in the model as volumes return.
  • Data-centre optionality: The Data Center Solutions unit generated $302.7m in calendar 2025 and the company expects ~65% growth to ~$500m in 2026, helped by new Gen6 PCIe switch and retimer products — a credible secular growth leg layered on a cyclical recovery.
  • Cash generation and dividend: Microchip produced $962.1m of operating cash flow and $871.0m of free cash flow in FY2026 and returned $984.0m to shareholders in dividends, supporting a quarterly payout it has raised for over two decades.

Bear Case

  • Heavy debt load: Long-term debt stood at $5,496.4m against $240.3m of cash and short-term investments at 31 March 2026, a legacy of the Microsemi and Atmel acquisitions, leaving the balance sheet far more leveraged than analog peers and sensitive to rates.
  • GAAP earnings still thin: Full-year GAAP EPS was just $0.22, weighed down by $431.1m of acquired-intangible amortisation, restructuring and $111.2m of preferred-stock dividends — a wide gap between reported and adjusted profitability.
  • Valuation has run ahead: The shares trade at roughly 10.8x trailing sales and a high-30s multiple of EBITDA after a strong rally, pricing in a robust, sustained recovery that depends on demand and inventory normalising on schedule.
  • End-market and macro sensitivity: Industrial (~31% of sales) and automotive (~17%) remain exposed to soft macro conditions, tariffs and customer inventory swings; a stall in the recovery would quickly pressure utilisation and margins again.

3. Business Segments

Microchip reports revenue across three principal product lines, supported by a broad design-tool and embedded-systems ecosystem. The split below reflects fiscal 2025 net sales (the most recent full-year product-line disclosure in the 10-K); fiscal 2026's mix is broadly similar, with data-centre and compute growing fastest.

Segment% of revenueWhat it is
Mixed-signal microcontrollers~51%8/16/32-bit MCUs and dsPICs — the core franchise embedded in industrial, automotive and consumer designs.
Analog~26%Power management, interface, mixed-signal, timing and security analog products that attach to the MCU base.
Other (FPGA, memory, licensing, MSS)~23%FPGAs, specialised memory, technology licensing and Microchip Storage Solutions, including the fast-growing data-centre connectivity portfolio.

By end market in fiscal 2026, industrial was ~31% of sales, data centre & compute ~18% and automotive ~17%, with the balance across aerospace & defence, communications and consumer.

4. Business Model and Economics

How it makes money. Microchip sells proprietary embedded-control silicon — microcontrollers, analog and FPGAs — into roughly 100,000 customers, mostly through long design-in cycles where its chips become entrenched in a customer's product for years. Revenue is recognised when control of product passes to the customer or distributor; the company deliberately manages towards end-demand rather than stuffing the channel, which is why distributor inventory (26 days at March 2026, near the low end of its range) is watched closely.

Unit economics and the recovery model. The business is high-gross-margin (non-GAAP gross margin 58.5% for FY2026 and 61.6% in the March quarter) but highly operating-leveraged: when factory utilisation falls, under-absorption charges crush margins, and when it rebuilds, incremental volume drops through at high contribution. That is the core of the "nine-point recovery plan" — cutting inventory (down $320.9m from the December 2024 peak), restoring utilisation and letting fixed-cost absorption lift margins. Capital intensity is modest in the current phase, with FY2027 capex guided to only ~$100m.

Capital returns. Free cash flow funds a long-standing and regularly raised dividend ($984.0m paid in FY2026); buybacks have been paused while the company prioritises de-leveraging after the downturn.

5. Financial Health

All figures below are taken from Microchip's fiscal 2026 fourth-quarter and full-year earnings release (7 May 2026) and prior-year press releases / 10-K balance sheets. Microchip's fiscal year ends 31 March.

Fiscal YearRevenueYoY %GAAP EPSAdjusted EPSDividend/shareLong-term debt (YE)
FY2022$6,820.9m+25.4%$2.27$4.61~$0.90
FY2023$8,438.7m+23.7%$4.02$6.02~$1.25$5,041.7m
FY2024$7,633.9m−9.5%$3.48$4.92~$1.56$5,000.4m
FY2025$4,401.6m−42.3%$(0.01)$1.31~$1.78$5,630.4m
FY2026$4,713.1m+7.1%$0.22$1.64~$1.82$5,496.4m

Quarterly progression through fiscal 2026 (most recent first):

QuarterRevenueAdjusted EPSGAAP EPS
Q4 FY2026 (Mar 2026)$1,311.2m$0.57$0.21
Q3 FY2026 (Dec 2025)$1,186.0m$0.44$0.06
Q2 FY2026 (Sep 2025)$1,140.0m$0.35$0.03
Q1 FY2026 (Jun 2025)$1,075.5m$0.27$(0.09)
FY2026 total$4,713.1m$1.64$0.22

The picture is a textbook trough-and-recovery: revenue more than halved from the FY2023 peak to FY2025, then turned up through FY2026 with each quarter sequentially stronger. GAAP EPS remains depressed by acquisition-intangible amortisation and preferred dividends, while non-GAAP EPS ($1.64) better reflects underlying earnings power. Long-term debt of $5,496.4m, down modestly from $5,630.4m a year earlier, is the key balance-sheet watch-item; cash and short-term investments fell to $240.3m as the company prioritised the dividend and debt service through the trough.

6. Valuation

Raw metrics, June 2026. Not opinions on whether the stock is cheap or expensive.

MetricValue
Market cap~$51.0bn (price ~$88, late June 2026)
Trailing P/E (GAAP)~400x (price ~$88 ÷ FY2026 GAAP EPS $0.22) — distorted by the cyclical trough, $431m of acquisition-intangible amortisation and preferred dividends; on non-GAAP EPS of $1.64 it is ~54x
P/E (forward)~32x (price ~$88 ÷ annualised Q1 FY2027 non-GAAP EPS guidance of ~$0.69 × 4 = ~$2.76; the recovery is expected to build through the year, so the forward multiple falls as quarterly EPS rises)
P/S (TTM)~10.8x (market cap ~$51.0bn ÷ FY2026 revenue $4.713bn)
Enterprise value~$56.3bn (market cap ~$51.0bn + total debt ~$5.496bn − cash & short-term investments $0.240bn per the 31 Mar 2026 balance sheet)
EV/EBITDA (TTM)~37x on TTM EBITDA (~$1.50bn). On a strict GAAP basis (operating income $490m + D&A ~$583m, of which $431m is acquisition-intangible amortisation) EBITDA ≈ $1.07bn → ~53x; both depressed versus normalised earnings power by the cyclical trough
P/FCF~59x (market cap ~$51.0bn ÷ FCF $871m; FCF = operating cash flow $962.1m − capex $91.1m per the FY2026 cash-flow reconciliation)
52-week high$105.91
52-week low$48.52
Short interest (% of float)~5% of float (most recent reported; ~27.6m shares)
Days to cover~3 days

7. What They Are Building

Microchip's growth investment is concentrated where embedded control meets high-performance data movement. The clearest example is its Data Center Solutions business, where the company has introduced an industry-first 3nm Gen6 PCIe switch and a new Gen6 PCIe retimer line with backward compatibility, aimed at the increasingly complex interconnect inside AI and cloud servers. Management expects that unit to grow from $302.7m in calendar 2025 to roughly $500m in 2026. Beyond data centre, the company continues to expand its 32-bit microcontroller and analog portfolios, security and connectivity products, and is selectively adding capacity and R&D equipment even as it has paused most factory-expansion spending and is evaluating the sale of its Fab 2 wafer fabrication facility to streamline manufacturing. The strategy is to ride the cyclical recovery in its core industrial and automotive franchises while layering on a faster-growing data-centre connectivity leg.

8. Competitive Landscape

Microchip competes across microcontrollers and analog against a set of large, well-capitalised broadline semiconductor peers. Market caps are as of late June 2026.

PeerMarket cap (Jun 2026)Key 2025 metric
Texas Instruments (TXN)~$267bnLargest analog franchise; broad industrial/automotive exposure
Analog Devices (ADI)~$206bnHigh-performance analog and mixed-signal leader
NXP Semiconductors (NXPI)~$75bnAutomotive and industrial MCU/processor specialist
Microchip (MCHP)~$51bnFY2026 net sales $4.713bn; broadline MCU + analog

Against these peers Microchip is the most leveraged and was among the hardest hit in the 2024–25 downturn, but it carries a differentiated breadth of microcontroller, analog, FPGA and connectivity products and a deep design-tool ecosystem that creates high switching costs in embedded designs.

9. Leadership and Ownership

Microchip is led by Steve Sanghi, who serves as President, Chief Executive Officer and Chair of the Board — the long-time leader who returned to steer the company through its recovery — alongside CFO Eric Bjornholt and COO Rich Simoncic. Recent insider Form 4 activity has been routine equity compensation rather than open-market conviction trades: CFO Eric Bjornholt's restricted/performance stock units converting (with shares withheld for taxes) and CEO Steve Sanghi receiving routine restricted-stock-unit grants in 2026.

NameDateTypeSharesPriceValuePlan Type
Eric Bjornholt (CFO)15 May 2026RSU/PSU conversion6,422~$93.85~$0.60mEquity comp vesting
Steve Sanghi (CEO/Chair)2026RSU grant3,446n/an/aEquity comp award

There has been no material open-market insider buying or selling disclosed in recent filings; the transactions above are part of normal executive compensation.

10. Key Risks

  • Financial leverage (Balance sheet): $5,496.4m of long-term debt against only $240.3m of cash and short-term investments leaves limited cushion and meaningful interest cost; refinancing or a stalled recovery could pressure the dividend and de-leveraging plan.
  • Cyclicality (Demand): Semiconductor demand is highly cyclical; the FY2025 collapse showed how fast revenue and utilisation can fall, and a renewed inventory correction would quickly reverse the recent margin gains.
  • Valuation re-rating (Market): With the shares up sharply and trading at a high-30s EV/EBITDA and ~10.8x sales, any disappointment versus the guided recovery trajectory could trigger a sharp de-rating, as the late-June 2026 sector sell-off illustrated.
  • End-market concentration (Operational): Industrial and automotive together are roughly half of sales and remain exposed to weak macro conditions, tariffs and customer order volatility.
  • Execution on data centre (Strategic): The ~65% data-centre growth assumption and new Gen6 PCIe products must win designs against entrenched competitors; slower adoption would remove an important growth narrative supporting the multiple.
  • Geopolitical and tariff exposure (Macro): Significant manufacturing and sales exposure to China, Europe and global supply chains makes results sensitive to tariffs, export controls and currency moves.

11. Recent Developments

  • 07 May 2026 — Q4 and full-year FY2026 results beat guidance. Microchip reported March-quarter net sales of $1.311bn (up 35.1% YoY, above the $1.260bn guided midpoint), GAAP EPS of $0.21 and non-GAAP EPS of $0.57, and full-year revenue of $4.713bn (+7.1%); it guided the June 2026 quarter to ~$1.442–1.469bn.
  • 07 May 2026 — Dividend declared. The Board declared a quarterly common dividend of $0.455 per share, payable 5 June 2026, continuing more than two decades of dividend payments.
  • 01 June 2026 — Data Center Solutions disclosure. Microchip detailed that its data-centre unit generated $302.7m in calendar 2025 and is expected to grow ~65% to ~$500m in 2026, with March-quarter data-centre revenue up 62.9% year over year.
  • 23 June 2026 — Semiconductor sell-off. Microchip shares fell alongside Analog Devices and other chip names during a broad late-June sector pullback, even as the company's own fundamentals continued to recover.
  • Ongoing — Fab 2 evaluation. Management continues to evaluate restructuring actions including a potential sale of its Fab 2 wafer fabrication facility, the gains or charges from which are excluded from current GAAP guidance.

12. Key Dates

  • 04 Aug 2026 — Expected Q1 FY2027 earnings (after market close; date per current consensus)
  • 05 Jun 2026 — Q4 FY2026 common dividend of $0.455/share paid (record date 22 May 2026)
  • 15 Jun 2026 — Series A preferred dividend paid (record date 1 June 2026)
  • Expected November 2026 — Q2 FY2027 earnings

Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.

Explore more on ChartsView: Live Charts · Economic Calendar · Community Forum.

Loading research report…

13. Thesis Verdict

Thesis strength
Moderate
64 / 100

The central thesis. Microchip designs and sells proprietary embedded-control silicon — microcontrollers, analog and FPGAs — into roughly 100,000 customers across industrial, automotive and data-centre markets, earning high gross margins through long, sticky design-in cycles. Fiscal 2026 revenue rose 7.1% to $4.713bn with the March quarter up 35.1% year over year; GAAP EPS was $0.22 and non-GAAP EPS $1.64, and management guided the June 2026 quarter to ~$1.456bn at the midpoint as its nine-point recovery plan restores factory utilisation and margins. The primary near-term driver is the cyclical recovery, layered with a fast-growing data-centre connectivity unit guided to ~65% growth in 2026.

What would confirm or break it. The thesis is confirmed by continued sequential revenue and margin gains and by data-centre design wins landing on plan across subsequent filings. It is invalidated by a renewed inventory or demand downturn, by strain on the heavily leveraged balance sheet ($5.5bn long-term debt against $0.24bn cash), or by a stall in the recovery that re-compresses utilisation and the margins the current valuation depends on.

Watchpoints

  • ConfirmsQ1 FY2027 earnings (36 days) landing in line with or above management guidance.
  • ConfirmsEvidence supporting the "Cyclical recovery underway:" thesis continuing to build across subsequent filings.
  • InvalidatesMaterialisation of the "Financial leverage (Balance sheet):" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.

Diagnostic grid

Bull vs Bear
4 : 4
Peer score
— n/a
5y trend
Positive
High-sev risks
0 of 6
Recent news
Net upgrades
Generated
29 Jun 2026
Weak · 0–40 Moderate · 41–70 Strong · 71–100

Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 29 Jun 2026.